Making History


BMI Enters the Battle on the COVID-19 VIRUS:

BioMedInnovations LLC., (BMI) a medical device company, makes precision air and fluid flow devices and products-in-development for lung ventilators and ex vivo tissue perfusion.  BMI intends to bring an emergency use lung ventilator to patients and critical care providers in COVID-19 crisis rapidly and in large volume.   These new ventilators will be capable of breathing support for patients affected by COVID-19. The BMI ventilators are designed to deliver room air and can also be attached to an Oxygen supply if one is available.  BMI is collaborating with it’s NC business connections, including motorsports and others, to create rapid response manufacturing capacity of BMI’s designs and feasibility prototypes.

Please see links to CBS and NBC news articles on our NEWS page for the latest information! Click HERE!

Get to Know
Our Staff Members

Broaden your horizons by meeting the BioMedInnovations management team, and astute board of directors. See more!

Ground-breaking Technology

Read more about this new, ground-breaking science, and what we envision for the future of organ perfusion. ​Read more!

Publications and Patents Earned

We are proud to share our past achievements in publications and patents earned surrounding this science. Learn more!

113000 transplant candidates will die this year if they don't receive an organ
Demand exceed supply because many organs time out before they can be placed in a candidate's body

This is game-changing... It's also life-changing.

BMI challenges the common belief that there are not enough transplantable organs to meet the demand. The Company redefines the problem as a “shortage of confirmed viable organs available for transplant”—not simply a shortage of organ donors. Understanding this distinction inspired BMI to develop CaVESWave®, which we believe is the most significant technological advances in the field of tissue perfusion in the past 40 years!
Pre-clinical testing demonstrated that CaVESWave® preserves organs longer than does current technology, and that it provides real-time organ metrics. Pre-clinical testing also validated that the CaVESWave® system not only keeps organs “alive” and fully-functional after being explanted, but it provides detailed, real-time organ performance and viability data, previously unavailable! This science may help eliminate unnecessary deaths in those patients waiting for organs!

Follow BioMedInnovations LLC on Social

CaVESWave® is an investigative device in the preclinical stage of development. It has not yet been tested extensively on humans or approved for commercial sale by the FDA or by any other regulatory body. ©BMI Proprietary and Confidential